Jrsis Health Care Corp Receivables Turnover Ratio (JRSS), from the third quarter 2024 to the third quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Jrsis Health Care Corp  (JRSS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Jrsis Health Care Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Jrsis Health Care Corp's ability to collect accounts receivable sequentially worsen to 10.39, indicating more challenging environment then in the second quarter 2024, but still, it is a far cry from any concerns. Jrsis Health Care's Accounts Receivable average collection period in the Sep 30 2024 quarter, has increased to 35 days, from 22 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 15 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 177, from overall ranking in the second quarter 2024 at 771.

What is Receivable Turnover Ratio?
What is Jrsis Health Care Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JRSS Receivables Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Receivable Change 25219.15 % 1124.04 % 3334.71 % 20597.73 % -6.62 %
Y / Y Revenue Change 1543.12 % 1279.13 % 4.91 % - -
Receivable Turnover Ratio (TTM) 10.39 16.36 17.28 19.27 -
JRSS's Total Ranking # 177 # 771 # 0 # 0 #
Accounts Receivable average collection period days 35 22 21 19 -
Seq. Receivable Change 252.71 % 97.64 % -87.04 % 27932.44 % -82.95 %
Seq. Revenue Change -62.68 % 19.38 % -85.3 % 24998.02 % -68.68 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 16
Overall Market # 177

Receivable Turnover Ratio Statistics
High Average Low
3.84 0.18 -21.34
(Dec 31 2023)   (Sep 30 2023)





JRSS Company Profile • Back to JRSS Efficiency Comparisons • Compare JRSS Receivables Turnover Ratio to its Competitors

Financial Statements
Jrsis Health Care's Accounts Receivable $ 1 Millions Visit JRSS's Balance sheet
Jrsis Health Care's Sales TTM $ 5 Millions Visit JRSS's Income Statement
Sources of JRSS's Revenues Visit JRSS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
JRSS's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
JRSS's Growth Rates JRSS's Roa JRSS's Inventory Turnover Ratio JRSS's Dividend Comparisons
JRSS's Profitability Ratios JRSS's Roi JRSS's Asset Turnover Ratio JRSS's Dividend Growth
JRSS's Valuation Ratios JRSS's Roe JRSS's Financial Strength Ratios JRSS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Receivable at quarter ending Sep 30 2024
Hookipa Pharma inc   17.97 $ 49.999  Millions$ 2.782  Millions
Macrogenics Inc   17.38 $ 141.329  Millions$ 8.132  Millions
Zomedica Corp   17.34 $ 25.965  Millions$ 1.497  Millions
Talkspace Inc   16.98 $ 179.853  Millions$ 10.591  Millions
Medinotec Inc   16.59 $ 7.309  Millions$ 0.441  Millions
Scorpius Holdings inc   16.51 $ 10.044  Millions$ 0.608  Millions
Sangamo Therapeutics Inc   16.48 $ 52.291  Millions$ 3.173  Millions
Stablecoin Development Corporation  16.33 $ 11.199  Millions$ 0.686  Millions
Nexalin Technology Inc   16.24 $ 0.162  Millions$ 0.010  Millions
Inmed Pharmaceuticals Inc  16.11 $ 4.284  Millions$ 0.266  Millions
Precipio inc   16.07 $ 17.411  Millions$ 1.084  Millions
Fortress Biotech Inc   15.68 $ 62.501  Millions$ 3.986  Millions
Icu Medical Inc  14.80 $ 2,340.754  Millions$ 158.125  Millions
Biofrontera Inc   14.40 $ 61.432  Millions$ 4.265  Millions
Bgm Group Ltd  14.36 $ 24.115  Millions$ 1.679  Millions
Valion Bio Inc   14.02 $ 0.957  Millions$ 0.068  Millions
Mannkind Corporation  14.00 $ 267.200  Millions$ 19.086  Millions
Ispecimen inc   13.70 $ 10.391  Millions$ 0.758  Millions
Qhslab Inc   13.69 $ 1.821  Millions$ 0.133  Millions
Lftd Partners Inc   13.08 $ 42.366  Millions$ 3.239  Millions
Escalon Medical Corp   13.07 $ 11.818  Millions$ 0.904  Millions
Patterson Companies Inc   13.07 $ 6,555.862  Millions$ 501.549  Millions
Nrc Health  12.92 $ 144.154  Millions$ 11.155  Millions
Chemed Corporation  12.84 $ 2,377.206  Millions$ 185.072  Millions
Vaxart Inc   12.79 $ 16.760  Millions$ 1.311  Millions
Vsee Health Inc   12.73 $ 8.115  Millions$ 0.637  Millions
International Stem Cell Corporation  12.65 $ 8.528  Millions$ 0.674  Millions
Poseida Therapeutics Inc   12.52 $ 150.858  Millions$ 12.053  Millions
Petvivo Holdings Inc   12.46 $ 0.969  Millions$ 0.078  Millions
American Oncology Network Inc   12.37 $ 1,592.782  Millions$ 128.721  Millions

Date modified: 2026-10-07T00:41:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.